Endovascular Treatment Devices Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, South Korea, Mexico, Brazil, Saudi Arabia, South Africa), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Endovascular Treatment Devices Market size is expected to grow significantly from 2019 to 2025.
 

Increasing incidence of aneurysm and ischemic strokes will be a high impact rendering factor for endovascular treatment devices market growth over the forecast timeframe. Endovascular devices such as stent-retriever have pivotal role in treatment of aneurysms. Treatment done with the usage of endovascular devices gives superior functional outcomes as compared to other available alternative medical therapies. It is used for embolization, flow disrupters and flow diverters that enhanced patient outcome from earlier treatment. As a result, rising cases of ischemic strokes and aneurysms will escalate demand for endovascular treatment devices in coming years.
 

Growing inclination towards minimally invasive procedure will prove beneficial for endovascular treatment devices market growth in forthcoming future. Industry players engaged in manufacturing of endovascular treatment devices have developed innovative solutions that can be efficiently used in cerebral aneurysms. Minimally invasive procedures have several benefits such as low requirement for blood transfusions, less precession that further results in minimum complexities post-surgical procedures. However, stringent regulatory scenario may hamper market growth to certain extent.
 

Biodegradable stents segment of endovascular treatment devices market is anticipated to witness substantial growth in coming years. Biodegradable stents are an excellent substitute for permanent stents and they also can deliver more drug to the targeted site as compared to thin coating of drug on metallic stents. Biodegradable stent deployed under fluoroscopic guidance that would situate and target lesion with minimal endovascular trauma. Later, stent itself gets disappear in few months that resolves the issue regarding mechanical stability and inflammation.
 

Neurology segment had lucrative revenue in 2018 and it is anticipated to witness significant growth over the analysis timeframe. Endovascular treatment devices are used to provide care to patients with intracranial aneurysms to prevent complexed outcomes. These devices have wider applications in treating several neurological disorders such as epilepsy, stroke, traumatic brain injury (TBI), Alzheimer’s and Parkinson’s disease, brain tumors and spinal cord injury. As a result, ample surgeries performed with the help of endovascular treatment devices will augment market growth in near future.
 

Hospitals segment is anticipated to witness momentous growth over the forecast period. Now-a-days, government of developing countries are highly expending on healthcare domain in order to upgrade overall facilities and infrastructure. As a result, hospitals are incorporating technologically advanced endovascular treatment devices that results in providing superior quality services to patients. As a result, availability of well-equipped devices will enhance clinical outcome that will benefit the segment growth in coming years.
 

North America endovascular treatment devices market had lucrative revenue share in 2018 and it is anticipated to witness substantial growth in near future. Increasing prevalence of chronic disorders such as cardiovascular, pulmonary, neurology and vascular diseases will escalate demand for endovascular treatment devices. Moreover, increasing affordability amongst people plays crucial role for regional growth.
 

Some of the notable industry players operating in the endovascular treatment devices market includes Nellix, Terumo Corporation, Lifetech Scientific, Orchestra BioMed, Cardinal Health, InspireMD, Lombard Medical Technologies, Boston Scientific and Endospan. These industry players implement various strategies such as mergers, acquisitions, product launches, emphasis on R&D activities, collaborations, etc. Such activities enable companies to grab higher market share and sustain competition. For instance, in June 2019, Orchestra BioMed announced collaboration with Terumo Corporation for development and launching Virtue Sirolimus Eluting Balloon. This product launch will strengthen company’s product portfolio especially in the U.S and globally. Product launches will enable company to capture higher market share.
 

Endovascular Treatment Devices Market By Product Type, 2014-2025 (USD Million)

• Percutaneous endovascular aneurysm repair (EVAR)
• Biodegradable Stents
• Fenestrated EVAR
• Self-expanding Nitinol Stents
• Aortic stents
• Thoracic aortic aneurysms grafts
• Other Devices

Endovascular Treatment Devices Market By Application, 2014-2025 (USD Million)

• Pulmonary
• Vascular
• Cardiology
• Neurology
• Others

Endovascular Treatment Devices Market By End User, 2014-2025 (USD Million)

• Hospitals
• Clinics
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa
  • Saudi Arabia
  • South Africa

Company Profiles:

• Nellix
• Terumo Corporation
• Lifetech Scientific
• Orchestra BioMed
• Cardinal Health
• InspireMD
• Lombard Medical Technologies
• Boston Scientific
• Endospan

What Information does this report contain?